Suppr超能文献

AOA 39、D600、维拉帕米和地尔硫䓬与心脏胆碱能效应的相互作用。

Interaction of AOA 39, D600, verapamil and diltiazem with cardiac cholinergic effects.

作者信息

Mubagwa K, Carmeliet E

出版信息

Arch Int Pharmacodyn Ther. 1987 Mar;286(1):71-84.

PMID:3592862
Abstract

The influence of the organic calcium channel blockers D600 and verapamil on cardiac cholinergic effects was studied using standard electrophysiological techniques on rabbit atrial strips, and using the two-microelectrode voltage-clamp technique on rabbit Purkinje fibers. The interaction between the above drugs as well as between AQA-39, diltiazem or nifedipine and muscarinic receptors was investigated using tritiated quinuclidinylbenzilate ([3H]QNB) binding on rabbit atrial homogenates. The electrophysiological experiments show that D600 and verapamil, at high concentrations (greater than 10(-6) M), inhibit the hyperpolarization and the increase in K+ conductance induced by acetylcholine. The binding experiments show that this inhibitory action of Ca2+ antagonists is due to an interaction at the level of muscarinic receptors. All the Ca2+ channel blockers used, except nifedipine, behave like classical muscarinic antagonists as shown by a 1 to 1 reaction between drug and receptor molecules. Because of the low affinity for the interaction between the Ca2+ channel blockers and muscarinic receptors, the clinical importance of this antimuscarinic effect is probably negligible.

摘要

采用标准电生理技术,在兔心房肌条上研究了有机钙通道阻滞剂D600和维拉帕米对心脏胆碱能效应的影响;并采用双微电极电压钳技术,在兔浦肯野纤维上进行了此项研究。运用氚化喹核醇基苯甲酸酯([3H]QNB)与兔心房匀浆结合的方法,研究了上述药物之间以及AQA-39、地尔硫䓬或硝苯地平与毒蕈碱受体之间的相互作用。电生理实验表明,高浓度(大于10⁻⁶ M)的D600和维拉帕米可抑制乙酰胆碱诱导的超极化和钾离子电导增加。结合实验表明,钙拮抗剂的这种抑制作用是由于在毒蕈碱受体水平上的相互作用。除硝苯地平外,所有使用的钙通道阻滞剂均表现为典型的毒蕈碱拮抗剂,药物与受体分子之间呈1:1反应。由于钙通道阻滞剂与毒蕈碱受体相互作用的亲和力较低,这种抗毒蕈碱效应的临床重要性可能微不足道。

相似文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验